Showing 1 - 1 of 1 trials – Showing only trials currently accepting patients
-
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma
Stanford is currently accepting patients for this trial.